万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>牙科与口腔外科

ORAL DISEASES《口腔疾病》 (官网投稿)

简介
  • 期刊简称ORAL DIS
  • 参考译名《口腔疾病》
  • 核心类别 SCI期刊(2019), SCIE期刊(2019), 外文期刊,
  • IF影响因子2.613
  • 自引率12.30%
  • 主要研究方向医学-DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科

主要研究方向:

等待设置主要研究方向
医学-DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科

ORAL DISEASES《口腔疾病》(一年8期). Oral Diseases is a multidisciplinary and international journal with a focus on head and neck disorders, ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://onlinelibrary.wiley.com/journal/16010825

3、投稿网址:http://mc.manuscriptcentral.com/odi

4、官网邮箱:odiedoffice@wiley.com(编辑部)

giovanni.lodi@unimi.it

5、期刊刊期:一年出版8期。

2021531日星期一

                             

 

投稿须知【官网信息】

 

Author Guidelines

Oral Diseases now offers Free Format submission for a simplified and streamlined submission process; More details here

Content of Author Guidelines: 1. General, 2. Ethical Guidelines, 3. Manuscript Submission Procedure, 4. Manuscript Types Accepted, 5. Manuscript Format and Structure, 6. After Acceptance.

Relevant Documents: Open Access Order Form, Standard Release Form for photographic consent

Useful Websites: Submission Site, Articles Published in Oral Diseases, Author Services, Wiley-Blackwell’s Ethical Guidelines, Guidelines for Figures

1. GENERAL

The editors encourage submissions of original articles, review articles, reports of meetings, book reviews and correspondence in the form of letters to the editor. Oral Diseases does not accept case reports.

Please read the instructions below carefully for details on the submission of manuscripts, the journal's requirements and standards as well as information concerning the procedure after a manuscript has been accepted for publication in Oral Diseases. Authors are encouraged to visit Wiley Author Services for further information on the preparation and submission of articles and figures.

Preprint Policy

Please find the Wiley preprint policy here. Oral Diseases accepts articles previously published on preprint servers. Oral Diseases will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.

Data Sharing and Data Accessibility

Oral Diseases expects data sharing. All accepted manuscripts will need to publish a data availability statement to confirm the presence or absence of shared data. The journal expects authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Sample statements are available here. If published, statements will be placed in the heading of your manuscript.

2. ETHICAL GUIDELINES

Oral Diseases adheres to the ethical guidelines given below for publication and research.

2.1. Authorship and Acknowledgements

Authorship: Oral Diseases adheres to the International Standards for Authors published by the Committee on Publication Ethics (COPE). All authors named on a paper should agree to be named on the paper, and all authors so named should agree to the submission of the paper to Oral Diseases and approve the submitted and accepted versions of the publication. Any change to the author list should be approved by all authors, including any author who has been removed from the list.

Oral Diseases also adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3.

It is a requirement that the corresponding author submit a short description of each individual's contribution to the research and its publication. Upon submission of a manuscript all co-authors should also be registered with a correct e-mail addresses. If any of the e-mail addresses supplied are incorrect, the corresponding author will be contacted by the Journal Administrator.

For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy), for more information please see Author Services.

Acknowledgements: Authors must acknowledge individuals who do not qualify as authors but who contributed to the research. Authors must acknowledge any assistance that they have received (e.g. provision of writing assistance, literature searching, data analysis, administrative support, supply of materials). If/how this assistance was funded should be described and included with other funding information. “Acknowledgements” should be brief and should not include thanks to anonymous referees and editors. Where people are acknowledged, a cover letter demonstrating their consent must be provided.

2.2. Ethical Approvals

Human Subjects: Experimentation involving human subjects will only be published if such research has been conducted in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki (version 2002) and the additional requirements, if any, of the country where the research has been carried out. Manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject and according to the above mentioned principles. A statement regarding the fact that the study has been independently reviewed and approved by an ethical board should also be included.

Photographs of People: Oral Diseases follows current HIPAA guidelines for the protection of patient/subject privacy. If an individual pictured in a digital image or photograph can be identified, his or her permission is required to publish the image. The corresponding author must either submit a letter signed by the patient authorizing Oral Diseases to publish the image/photo, or complete the 'Standard Release Form for photographic consent' available at the top of this page or by clicking the “instructions and Forms” link on the ScholarOne Manuscripts submission site. The approval must be received by the Editorial Office prior to final acceptance of the manuscript for publication. Otherwise, the image/photo must be altered such that the individual cannot be identified (black bars over eyes, tattoos, scars, etc.). Oral Diseases will not publish patient photographs that will in any way allow the patient to be identified, unless the patient has given their express consent.

Editors reserve the right to reject papers if there are doubts as to whether appropriate procedures have been used.

Animal Study: When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations.

2.3 Clinical Trials

Clinical Trials should be reported using the CONSORT guidelines available at www.consort-statement.org. A CONSORT checklist and flowchart should also be included in the submission material. Clinical trials can be registered in any free, public clinical trials registry such as http://www.clinicaltrials.gov or http://isrctn.org/. A list of further registries is available at http://www.who.int/ictrp/network/primary/en/. As stated in an editorial published in Oral Diseases (12:217-218), 2006), all manuscripts reporting results from a clinical trial must indicate that the trial was fully registered at a readily accessible website. The clinical trial registration number and name of the trial register will be published with the paper.

2.4 DNA Sequences and Crystallographic Structure Determinations

Papers reporting protein or DNA sequences and crystallographic structure determinations will not be accepted without a Genbank or Brookhaven accession number, respectively. Other supporting data sets must be made available on the publication date from the authors directly.

2.5 Conflict of Interest and Source of Funding

All sources of institutional, private and corporate financial support for the work within the manuscript must be fully acknowledged, and any potential grant holders should be listed. Authors are also required to disclose any possible conflict of interest. These include financial (for example patent, ownership, stock ownership, consultancies, speaker’s fee). Information on sources of funding and any potential conflict of interest should be disclosed at submission under the heading “Acknowledgements”.

2.6 Appeal of Decision

The decision on a paper is final and cannot be appealed.

2.7 Avoiding allegations of plagiarism

The journal to which you are submitting your manuscript employs text matching software (iThenticate) to ensure against plagiarism. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published work. Authors should consider whether their manuscript may raise concerns via iThenticate, which will signal whether a paper is likely in any way to be plagiarized in a formal sense. iThenticate will also, however, signal whether a paper may be plagiarized by repeating work of the submitting authors and thus be regarded as duplicate or redundant publication. Experience shows that, on occasion, large sections of submitted manuscripts can be close to verbatim in word choice from that seen in other papers from the authors’ group. This has nothing to do with simple repetition of names/affiliations, but does involve common (not necessarily "standard") phrases that are more appropriately referenced instead of repeating. Alternatively, they can be rephrased differently. Previously published results, including numerical information and figures or images, should be labeled to make it clear where they were previously reported. Papers that present new analyses of results that have already been published (for example, subgroup analyses) should identify the primary data source, and include a full reference to the related primary publications. Oral Diseases will review and publish accepted mansucripts that report data included in conference proceedings in abstract form. In such cases, authors must be clear to readers that part of all of the manuscript's data have already been published in abstract form by so indicating using a footnote to the title that states the confrence proceedings in which the relevant abstract was published. For full guidance on text matching and plagiarism, please refer to Section 3 ('Research Integrity') of Wiley's Ethics Guidelines at https://authorservices.wiley.com/ethics-guidelines/index.html.

2.8 Permissions

If all or parts of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author's responsibility to obtain these in writing and provide copies to the Publishers.

3. MANUSCRIPT SUBMISSION PROCEDURE

Oral Diseases only accepts online submission of manuscripts. Manuscripts should be submitted at the online submission site: http://mc.manuscriptcentral.com/odi. Complete instructions for submitting a manuscript are available at the site upon creating an account. Assistance for submitting papers can be sought with the editorial assistant at: odiedoffice@wiley.com

Data protection: By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

3.1. Manuscript Files Accepted

Manuscripts should be uploaded as Word (.doc/.docx) or Rich Text Format (.rft) files (not write-protected) plus separate figure files. GIF, JPEG, PICT or Bitmap files are acceptable for submission, but only high-resolution TIF or EPS files are suitable for printing. The files will be automatically converted to HTML and PDF on upload and will be used for the review process. The text file must contain the entire manuscript including title page, abstract, text, references, acknowledgements, tables, and figure legends, but no embedded figures. In the text file, please reference figures as for instance 'Figure 1', 'Figure 2' etc to match the tag name you choose for individual figure files uploaded. Manuscripts should be formatted as described in the Author Guidelines below.

3.2. Transparent Peer Review

This journal is participating in a Peer Review Transparency initiative. By submitting to this journal, authors agree that the reviewer reports, their responses, and the editor’s decision letter will be linked from the published article to where they appear on Publons in the case that the article is accepted. Authors have the opportunity to opt out during submission, and reviewers may remain anonymous unless they would like to sign their report. Read more about this initiative here.

3.3. Suggest a Reviewer

Oral Diseases attempts to keep the review process as short as possible to enable rapid publication of new scientific data. In order to facilitate this process, you must suggest the names and current e-mail addresses of from 2-4 potential reviewers whom you consider capable of reviewing your manuscript in an unbiased way.

3.4. Suspension of Submission Mid-way in the Submission Process

You may suspend a submission at any phase before clicking the 'Submit' button and save it to submit later. The manuscript can then be located under 'Unsubmitted Manuscripts' and you can click on 'Continue Submission' to continue your submission when you choose to.

3.5. E-mail Confirmation of Submission

After submission you will receive an e-mail to confirm receipt of your manuscript. If you do not receive the confirmation e-mail after 24 hours, please check your e-mail address carefully in the system. If the e-mail address is correct please contact your IT department. The error may be caused by some sort of spam filtering on your e-mail server. Also, the e-mails should be received if the IT department adds our e-mail server (uranus.scholarone.com) to their whitelist.

3.6. Manuscript Status

The average time from submission to first decision for manuscripts submitted to Oral Diseases is 20 days. You can access ScholarOne Manuscripts (formerly known as Manuscript Central) any time to check your 'Author Centre' for the status of your manuscript. The Journal will inform you by e-mail once a decision has been made.

3.7. Submission of Revised Manuscripts

To upload a revised manuscript, locate your manuscript under 'Manuscripts with Decisions' and click on 'Submit a Revision'. Please remember to delete any old files uploaded when you upload your revised manuscript.

4. MANUSCRIPT TYPES ACCEPTED

Original Research Articles: Manuscripts reporting laboratory investigations, well-designed and controlled clinical research, and analytical epidemiology are invited. Studies related to aetiology, pathogenesis, diagnosis, prevention and treatment are all of interest, but all papers must be based on rigorous hypothesis-driven research. Areas of interest include diseases affecting any structures of the mouth; cancer and pre-cancerous conditions; saliva and salivary glands; bone and hard tissues; relationaship between oral, periodontal, and dental conditions and general health; pain; behavioral dentistry; chemosensory, developmental, geriatric, and motor disorders.

Randomised trials must adhere to the CONSORT guidelines, and a CONSORT checklist and flowchart must be submitted with such papers. Please also refer to the notes under section 2.3 above.

Oral Diseases supports the ALLTRIALS initiative and encourages authors submitting manuscripts reporting a clinical trial to register the trials in any of the following free, public clinical trials registries: www.clinicaltrials.gov, http://clinicaltrials.ifpma.org/clinicaltrials/, http://isrctn.org/. The clinical trial registration number and name of the trial register will then be published with the paper.

Observational studies must adhere to the STROBE guidelines, and a STROBE checklist must be submitted with such papers. Diagnostic accuracy studies must adhere to the STARD guidelines, and a STARD checklist must be submitted with such papers.

Review Papers: Oral Diseases commissions review papers and also welcomes uninvited reviews. Systematic reviews with or without meta-analyses must adhere to the PRISMA guidelines, and a PRISMA checklist and flowchart must be submitted with such papers. The word limit for Review Papers is 4,000 words, with a maximum of two tables or images and 50 references.

Letters to the Editors: Letters, if of broad interest, are encouraged. They may deal with material in papers published in Oral Diseases or they may raise new issues, but should have important implications. Only one letter may be submitted by any single author or group of authors on any one published paper. Letters to the Editors should not include an abstract and are limited to 500 words, with a maximum of 1 figure and 10 references.

Case Reports: Oral Diseases does not accept case reports and instead recommends that authors submit to Clinical Case Reports an open access journal published by Wiley.

Meeting Reports: Will be considered by the editors for publication only if they are of wide and significant interest.

Short Communications: These are brief papers of any topic within the scope of Oral Diseasesabout significant and novel advances that are complete in research endeavor but not suitable for full publications. Short Communications should not include an abstract and are limited to 1000 words, with a maximum of 3 figures and 20 references. Short Communications should not be structured into sections.

Invited Reviews: These may be submitted by invitation of the Senior Editors only, and consist of around 2500-2750 words, with a maximum of one table or image and 25 references.

Commentaries: These may be submitted by invitation of the Senior Editors only.

Invited Editorials: These may be submitted by invitation of the Senior Editors only.

Invited Book Reviews: These may be submitted by invitation of the Senior Editors only.

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/16010825/homepage/forauthors.html


投稿问答最小化  关闭